Results 81 to 90 of about 52,980 (296)

Chronic Thoracic Aortic Aneurysm Presenting 29 Years following Trauma

open access: yesCase Reports in Surgery, 2015
Blunt, nonpenetrating injuries of the thoracic aorta are uncommon and associated with a high mortality rate within the first hour. Aortic injury is missed in 1-2% of patients that survive to hospital, and a chronic thoracic aortic aneurysm may ...
Sarah Miller   +3 more
doaj   +1 more source

The physical origin of aneurysm growth, dissection, and rupture [PDF]

open access: yesarXiv, 2023
Rupture of aortic aneurysms is by far the most fatal heart disease, with a mortality rate exceeding 80%. There are no reliable clinical protocols to predict growth, dissection, and rupture because the fundamental physics driving aneurysm progression is unknown.
arxiv  

Traumatic rupture of the aorta : a case report and discussion of clinical features [PDF]

open access: yes, 2012
A young female patient was involved in a head-on collision and sustained a rupture of the aortic isthmus. She underwent emergency surgical repair of an aortic pseudo-aneurysm with an interposition graft.
Casha, Aaron   +3 more
core  

Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms [PDF]

open access: yes, 2014
Elective root replacement in Marfan syndrome has improved life expectancy in affected patients. Three forms of surgery are now available: total root replacement (TRR) with a valved conduit, valve sparing root replacement (VSRR) and personalised external ...
Pepper, J, Takkenberg, JJM, Treasure, T
core   +3 more sources

Familial polyposis syndrome and achalasia in a young adult

open access: yesJPGN Reports, EarlyView.
Abstract We report the case of a 19‐year‐old White male diagnosed with familial adenomatous polyposis (FAP), Gardner's syndrome (GS) phenotype, status post total colectomy, who developed progressive dysphagia and weight loss. He was diagnosed with achalasia based on imaging and esophageal manometry.
Gabriella A. Lorusso Vivas   +2 more
wiley   +1 more source

Thoracic endovascular aortic repair with a right thoracotomy approach

open access: yesJournal of Cardiothoracic Surgery, 2022
Background The common femoral artery is usually the preferred access route for thoracic endovascular aortic repair (TEVAR). However, if access from the common femoral artery is challenging, other routes must be considered.
Hideki Tanioka   +2 more
doaj   +1 more source

Radiological Insights Into the Pericardium: A Comprehensive Review

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT The pericardium is not simply a two‐layered membrane surrounding the heart and great vessels. Pericardial effusion is the most common manifestation of various pathological conditions involving the pericardium. Therefore, we are tempted to think of the pericardium as a virtual space containing only fluid, but it can also contain solid and ...
Felipe Aluja‐Jaramillo   +4 more
wiley   +1 more source

Thoracic aorta cardiac-cycle related dynamic changes assessed with a 256-slice CT scanner [PDF]

open access: yes, 2013
Objective: The aim of our study was to demonstrate whether the dynamic changes previously documented at the ascending and abdominal aorta are replicated at the thoracic aorta.
Capuñay, Carlos   +7 more
core   +1 more source

Successful open surgical treatment for persistent type II endoleak following thoracic endovascular aortic repair: a case report

open access: yesJournal of Cardiothoracic Surgery
Background The occurrence of type II endoleaks after endovascular repair of aortic aneurysm has gradually gained increasing attention. We present a case of a patient with an expanding aneurysm after thoracic endovascular aortic repair (TEVAR) for a type ...
June Lee   +5 more
doaj   +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

open access: yesAnnals of Human Genetics, EarlyView.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy